Banque de Luxembourg S.A. Takes Position in Danaher Co. (NYSE:DHR)

Banque de Luxembourg S.A. bought a new position in shares of Danaher Co. (NYSE:DHR - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 4,746 shares of the conglomerate's stock, valued at approximately $1,094,000. Danaher makes up 0.6% of Banque de Luxembourg S.A.'s holdings, making the stock its 26th biggest position.

A number of other institutional investors have also added to or reduced their stakes in the business. Heck Capital Advisors LLC purchased a new position in shares of Danaher during the fourth quarter worth about $27,000. Decker Retirement Planning Inc. purchased a new position in Danaher in the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher in the 4th quarter worth $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher during the 4th quarter valued at $31,000. Finally, Pineridge Advisors LLC lifted its holdings in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after acquiring an additional 57 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Down 1.8 %

Shares of Danaher stock traded down $3.55 during midday trading on Friday, reaching $191.27. 2,656,514 shares of the company's stock traded hands, compared to its average volume of 3,389,539. The stock has a 50 day moving average of $198.72 and a 200-day moving average of $219.95. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70. The company has a market cap of $136.89 billion, a PE ratio of 36.23, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The firm had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. As a group, equities analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.67%. Danaher's dividend payout ratio is currently 24.85%.

Wall Street Analyst Weigh In

DHR has been the topic of a number of research reports. The Goldman Sachs Group lowered their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Guggenheim reissued a "buy" rating and set a $250.00 price objective on shares of Danaher in a report on Wednesday, April 23rd. Royal Bank of Canada restated an "outperform" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Jefferies Financial Group reduced their price target on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. cut their price objective on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $264.40.

Insider Activity

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.